The Foundation for the Study and Development of Biotherapies is a foundation hosted by the Fondation de France. This means that it benefits from the legal personality of the Fondation de France.

The administrative, legal and fiscal management of the Foundation is carried out by the teams of the Fondation de France.

A committee of volunteer directors proposes investment projects that are then validated by the Fondation de France teams.

This committee is composed of:

• Alain Dublanchet, physician, honorary hospital biologist, former head of the microbiology laboratory at the Villeneuve-Saint-Georges Hospital (Val-de-Marne), specialist in phagotherapy, author of the book La phagothérapie, des virus pour combattre les infections“.
• Gwénola du Boisguéheneuc, holder of a University Diploma in Mental Health, peer support specialist and speaker specializing in ADHD, neurodevelopmental disorders, and the impact of post-infectious syndromes.
• Jacques Le Marois, president of the Foundation, holds a research master’s degree in biology and biochemistry from the Ecole Normale Supérieure, co-founder and former director of the companies Mandrakesoft and Geneanet, as well as the associations Geneabank and Familles Parisiennes.
• Raphaël Scharfmann, Research Director at Inserm (Institut Cochin), internationally renowned researcher in endocrinology and cell therapy applied to pancreatic diseases and diabetes.
• Stéphanie Maugey, corporate director and private manager at Financière d’Uzès.
• Valérie Le Marois, Montessori educator, co-founder of the Foundation.